TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Cash Flow
NYSE:TEVA - New York Stock Exchange, Inc. - US8816242098 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.32B | -1.96B | -615.00M | -2.41B | 456.00M | |||
| Depreciation Amortization | 1.03B | 1.06B | 1.15B | 1.31B | 1.33B | |||
| Income Taxes - Deferred | -417.00M | -634.00M | -317.00M | -1.06B | -120.00M | |||
| Change In Working Capital | -637.00M | -435.00M | -72.00M | 1.26B | -1.70B | |||
| Interest Paid | N/A | 1.00B | 1.08B | 948.00M | 913.00M | |||
| Taxes Paid | N/A | 471.00M | 298.00M | 543.00M | 495.00M | |||
| Other non cash items | 2.61B | 3.22B | 1.22B | 2.49B | 833.00M | |||
| OPERATING CASH FLOW | 1.27B | 1.25B | 1.37B | 1.59B | 798.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -501.00M | -498.00M | -526.00M | -548.00M | -562.00M | |||
| Other Investing Activity | 1.35B | 1.29B | 1.49B | 1.20B | 2.08B | |||
| INVESTING CASH FLOW | 849.00M | 792.00M | 968.00M | 656.00M | 1.52B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.01B | -1.64B | -1.70B | -1.37B | -2.17B | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | N/A | N/A | |||
| Dividend Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Financing Activity | -375.00M | -150.00M | -212.00M | -118.00M | -6.00M | |||
| FINANCING CASH FLOW | -3.38B | -1.79B | -1.91B | -1.49B | -2.17B | |||
| Exchange Rate Effect | -25.00M | -174.00M | -30.00M | -123.00M | -128.00M | |||
| CHANGE IN CASH | -1.29B | 74.00M | 393.00M | 636.00M | 21.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.27B | 1.25B | 1.37B | 1.59B | 798.00M | |||
| Capital Expenditure | -501.00M | -498.00M | -526.00M | -548.00M | -562.00M | |||
| FREE CASH FLOW | 766.00M | 749.00M | 842.00M | 1.04B | 236.00M | |||
All data in USD